FDA approves melphalan as a liver-directed treatment for uveal melanoma
On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System) containing melphalan (HEPZATO, Delcath Systems, Inc.) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 15, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Hepzato Kit (melphalan) Hepatic Delivery System for the Treatment of Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
NEW YORK, Aug. 14, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug Administration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 14, 2023 Category: Drugs & Pharmacology Source Type: news
Determinants of Overall Survival in Metastatic Uveal Melanoma Identified
WEDNESDAY, July 12, 2023 -- Factors associated with improved survival in metastatic uveal melanoma include female sex and use of anti ‐cytotoxic T lymphocyte-associated antigen (CTLA)‐4 and anti‐programmed cell death protein 1 (PD-1) therapies,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2023 Category: Pharmaceuticals Source Type: news
My little girl was diagnosed with eye cancer - the warning sign was worryingly subtle
A mother from Putney has revealed the worryingly subtle sign her then-14-month-old daughter Isla Palul had eye cancer. Isla's parents Rebecca, 35, and Charlotte, 36, noticed her eye 'whizzing'. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2023 Category: Consumer Health News Source Type: news
Manglik, Arkin, Bastian receive ASPIRE Award for moonshot cancer research
Funding from the Mark Foundation for Cancer Research will fuel high-risk, high-impact research on uveal melanoma. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - February 23, 2023 Category: Universities & Medical Training Source Type: news
Manglik, Arkin, Bastian receive Mark Foundation ASPIRE Award for moonshot cancer research
Funding from the Mark Foundation for Cancer Research will fuel high-risk, high-impact research on uveal melanoma. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - February 23, 2023 Category: Universities & Medical Training Source Type: news
Treatment of Metastatic Uveal Melanoma in 2022 Treatment of Metastatic Uveal Melanoma in 2022
Recent developments in our understanding of metastatic uveal melanoma and treatment advancements have improved the prognosis of these patients. Find out what ' s new.Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 2, 2022 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Consumer Health: What do you know about these 3 rare childhood cancers?
Childhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed with cancer in 2022, according to the American Cancer Society. September is Childhood Cancer Awareness Month, which makes this a good time to learn about three rare types of cancers in children: retinoblastoma, rhabdomyosarcoma and Wilms' tumor. Retinoblastoma Retinoblastoma is a rare form of eye cancer that begins in the… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 26, 2022 Category: Databases & Libraries Source Type: news
Babies exposed to some pesticides while in womb are more likely to develop rare eye cancer
Scientists at the University of California, Los Angeles warned unborn babies were particularly at risk because their organs were still developing, leaving them more at risk of damage. (Source: the Mail online | Health)
Source: the Mail online | Health - September 16, 2022 Category: Consumer Health News Source Type: news
These pesticides may increase cancer risk in children
Key takeaways:Higher cancer risk. Prenatal exposure to acephate and other pesticides can increase the risk of retinoblastoma, or eye cancer, in children.Environmental causes. Children with retinoblastoma are more likely to be born in neighborhoods near applications of specific chemicals.Past research has shown that pesticide exposure increases the risk of cancer. Now, UCLA-led research has exposed which specific pesticides increase the risk of retinoblastoma — a rare eye tumor — in children.Thestudy, published in the August International Journal of Hygiene and Environmental Health, found that children prenatally expo...
Source: UCLA Newsroom: Health Sciences - September 13, 2022 Category: Universities & Medical Training Source Type: news
What Are the Symptoms of Eye Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 26, 2022 Category: General Medicine Source Type: news
The 'pioneering' new technique that could spot eye cancer - takes 'less than a second'
CANCER detection is currently undergoing a revolution thanks to the deployment of cutting-edge technology. Joining the fight to detect eye cancer faster and more cheaply is a "pioneering" new 3D device. (Source: Daily Express - Health)
Source: Daily Express - Health - July 13, 2022 Category: Consumer Health News Source Type: news
Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news
Eye cancer symptoms: Five signs in your vision to get checked 'as soon as possible'
EYE CANCER can impact your eyesight in a number of ways. Cancer Research UK explains: "Eye cancer is a general term that includes different cancer types. The type of cancer you have depends on the type of cell it starts in. There are different parts of the eye and some of these are more likely to get cancer than others." (Source: Daily Express - Health)
Source: Daily Express - Health - May 25, 2022 Category: Consumer Health News Source Type: news